| Completed | PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcino Superficial Basal Cell Carcinoma | Phase 2 | 2011-04-01 |
| Completed | PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing Healthy, Actinic Keratosis | Phase 1 | 2011-02-01 |
| Completed | Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-dam Photo-damage | Phase 2 | 2010-10-01 |
| Completed | Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Seborrheic Keratosis | Phase 2 | 2010-10-01 |
| Completed | A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at Actinic Keratosis | — | 2009-09-01 |
| Completed | A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies Actinic Keratosis | — | 2009-08-01 |
| Completed | A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Ac Actinic Keratoses | Phase 3 | 2009-07-01 |
| Completed | A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study Actinic Keratosis | — | 2009-07-01 |
| Completed | A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratosis | Phase 3 | 2009-06-01 |
| Completed | A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratosis | Phase 3 | 2009-06-01 |
| Completed | A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratosis | Phase 3 | 2009-06-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Us Actinic Keratosis | Phase 2 | 2009-03-01 |
| Completed | A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteer Actinic Keratosis | Phase 1 | 2009-02-01 |
| Completed | A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Actinic Keratosis | Phase 1 | 2009-02-01 |
| Completed | A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Ac Actinic Keratoses | Phase 3 | 2008-09-01 |
| Completed | A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Kerat Actinic Keratosis | Phase 2 | 2008-06-01 |
| Completed | Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 Actinic Keratosis | Phase 1 | 2008-04-01 |
| Completed | A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the T Actinic Keratosis | Phase 2 | 2007-10-01 |
| Completed | Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 Actinic Keratoses | Phase 1 | 2007-10-01 |
| Withdrawn | The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of C Warts | Phase 1 | 2007-10-01 |
| Completed | To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC Superficial Basal Cell Carcinoma | Phase 2 | 2007-02-01 |
| Completed | A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel Actinic Keratoses | Phase 2 | 2007-01-01 |
| Completed | Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses Actinic Keratosis | Phase 2 | 2006-09-01 |
| Completed | Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Healthy | Phase 1 | 2006-06-01 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma I Carcinoma, Squamous Cell | Phase 2 | 2006-05-01 |
| Completed | Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Keratosis | Phase 2 | 2005-09-01 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses Actinic Keratosis | Phase 2 | 2005-03-01 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma Basal Cell Carcinoma | Phase 2 | 2005-03-01 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma Basal Cell Carcinoma | Phase 2 | 2005-03-01 |